Complications of patients with multiple sclerosis after suffering from coronavirus infection
Keywords:
COVID-19; concomitant conditions; multiple sclerosis; severity of coronavirus infection; central nervous system.Abstract
Background SARS-CoV-2 is a single-stranded RNA virus belonging to the group of acute coronaviruses, and its infection causes the disease COVID-19. Coronavirus 2(SARS-CoV-2), accompanied by severe acute respiratory syndrome in 2019, requires special attention to patients with chronic diseases, especially those with diseases such as multiple sclerosis (MS), as MS is one of the most vulnerable groups. This is due to the fact that MS patients have a higher risk that the infection will lead to a change in the course of the disease and complications due to the fact that measures for the complete treatment of the disease have not been studied. Purpose of the study To study and analyze the consequences of the disease in patients with multiple sclerosis who have suffered coronavirus infection using a scientific database published in peer-reviewed journals indexed in PubMed, Web of Science, Scopus and RSCI. Results and conclusions This has also led to global, socio-economic consequences and an increase in the number of deaths. Currently, according to the latest statistical report for 04/13/2024, the number of people infected with COVID-19 worldwide has reached 704753890 people. Epidemiological studies have shown an approximately 30% increased risk of death from vascular diseases in MS patients after COVID-19. In addition, MS patients are particularly susceptible to the complications of COVID-19. Complications of common COVID-19 infection against the background of COVID–19 often developed complicated stroke, cerebral venous thrombosis, autoimmune encephalitis, acute multiple encephalomyelitis, Guillain-Barre syndrome. Studies have shown that cognitive dysfunction is the most common symptom of post-covid and has been observed in 70% of MS patients. Thus, arterial hypertension in patients with MS, i.e. in patients with concomitant diseases, is characterized by an increased risk of developing severe and critical forms of COVID-19 infection. In this literature review, we tried to summarize the available information on complications after COVID-19 by publishing data on MS in patients with SARS-CoV-2-related pathology.
Bangladesh Journal of Medical Science Vol. 25 No. 04 October’26 Page: 1227-1235
16
61
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Toremukhamet Akbota, Abassova Gaukhar, Zhumagulova Umit, Nurlybaeva Gulnaz, Yerezhepov Yerlan, Tursumetova Malika, Kozhakhmetova Sholpan, Alibek Rustembek, Buryshov Samat
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
